QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin

Chronic kidney disease (CKD) is becoming a worldwide problem. However, current treatment options are limited. In the current study we showed that QiShenYiQi (QSYQ), a water-ethanol extract from several Chinese medicines, is a potent inhibitor of renal interstitial fibrosis. QSYQ inhibited transformi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhanmei, Hu, Zheng, Li, Mei, Zhu, Fengxin, Zhang, Hao, Nie, Jing, Ai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026381/
https://www.ncbi.nlm.nih.gov/pubmed/27636716
http://dx.doi.org/10.1371/journal.pone.0162873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026381/
https://www.ncbi.nlm.nih.gov/pubmed/27636716
http://dx.doi.org/10.1371/journal.pone.0162873

Ejemplares similares